Rheumatoid Lung Disease

Area of Science:

• Rheumatology
• Pulmonology
• Immunology

Background:

• Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease impacting joints and causing extra-articular manifestations, notably lung disease.
• Pulmonary involvement in RA significantly contributes to patient morbidity and mortality, affecting airways, parenchyma, vasculature, and pleura.
• Interstitial lung disease (ILD) is the most severe parenchymal manifestation of RA.

Purpose of the Study:

• To review the diverse pulmonary manifestations of RA.
• To discuss screening methods for RA-associated lung disease.
• To explore the pathophysiology linking RA and lung disease, including the role of smoking.

Main Methods:

• Literature review of RA and associated lung disease.
• Analysis of genetic and environmental risk factors, focusing on smoking.
• Discussion of current understanding of RA pathogenesis concerning lung involvement.

Main Results:

• RA affects multiple lung compartments, with ILD being a critical concern.
• Cigarette smoking is a major risk factor for RA development in genetically predisposed individuals.
• Smoking promotes pulmonary inflammation, protein citrullination, and autoantibody generation, contributing to RA pathogenesis.

Conclusions:

• RA-associated lung disease is a serious complication requiring careful monitoring and management.
• Understanding the interplay between genetic susceptibility, environmental factors like smoking, and immune responses is crucial for RA pathogenesis.
• Recent therapeutic advances offer new hope for managing RA and its pulmonary manifestations.